---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-071011"
form_type: "8-K"
ticker: "EWTX"
cik: "0001710072"
company_name: "Edgewise Therapeutics, Inc."
filed_at: "2026-06-05T20:33:33+00:00"
generated_at: "2026-06-05T20:35:29.612709+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Edgewise Therapeutics stockholders elect three directors, ratify auditor, approve say-on-pay at 2026 annual meeting

## Summary
- Laura Brege (87.3M for), Badreddin Edris (64.1M for), Jonathan Root (59.2M for) elected Class II directors.
- KPMG LLP ratified as independent auditor for FY2026 with 99.6M for, 1.1K against, 578K abstain.
- Say-on-pay advisory vote approved: 87.1M for, 3.5M against, 577K abstain.

## SEC filing metadata
- accession: 0001104659-26-071011
- form_type: 8-K
- ticker: EWTX
- cik: 0001710072
- company_name: Edgewise Therapeutics, Inc.
- filed_at: 2026-06-05T20:33:33+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/tm2616953d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-071011
- JSON: https://secwatch.observer/filing/0001104659-26-071011.json
- Plain text: https://secwatch.observer/filing/0001104659-26-071011.txt

## Key facts
- Shareholder Votes
  Edgewise Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 99,637,228 1,123 578,031
  evidence_url: https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm
- Shareholder Votes
  Edgewise Therapeutics, Inc. shareholders approved Election of three Class II Directors at the 2026-06-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 1: Election of three Class II Directors Name of Director For Withheld Laura Brege 87,300,827 3,822,867 Badreddin Edris, Ph.D. 64,082,681 27,041,013 Jonathan Root, M.D. 59,213,781 31,909,913
  evidence_url: https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm
- Shareholder Votes
  Edgewise Therapeutics, Inc. shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 3: Advisory Vote on the Compensation of the Company's Named Executive Officers For Against Abstain 87,055,111 3,491,326 577,257
  evidence_url: https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.